| scholarly article | Q13442814 |
| P50 | author | Suet Yi Leung | Q67415790 |
| P2093 | author name string | Wei Zhao | |
| Tsun L Chan | |||
| Siu T Yuen | |||
| Cancer Genome Project | |||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4878-4881 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas | |
| P478 | volume | 63 |
| Q92620116 | A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers |
| Q80988302 | A case of multiple protruding and flat colorectal tumors analyzed by a cDNA array |
| Q27852431 | A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. |
| Q35071477 | A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome |
| Q37635945 | APC and its modifiers in colon cancer. |
| Q35475357 | Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum |
| Q38798435 | Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer |
| Q97543614 | After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation |
| Q35915905 | Apoptosis and colorectal cancer |
| Q47753304 | BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability |
| Q35588657 | BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs |
| Q42353442 | BRAF inhibitor treatment of melanoma causing colonic polyps: An alternative hypothesis |
| Q35596687 | BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum |
| Q36613576 | BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias |
| Q21245742 | BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status |
| Q35083792 | BRAF mutations in aberrant crypt foci and hyperplastic polyposis |
| Q28543370 | BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications |
| Q33868608 | BRAF, K-ras and BAT26 mutations in colorectal polyps and stool. |
| Q37457106 | Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation |
| Q34000694 | Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells |
| Q38690051 | British Society of Gastroenterology position statement on serrated polyps in the colon and rectum |
| Q28259527 | Cancer stem cells: the lessons from pre-cancerous stem cells |
| Q89638302 | Capicua suppresses colorectal cancer progression via repression of ETV4 expression |
| Q34369345 | Claudin-1 Expression Is Elevated in Colorectal Cancer Precursor Lesions Harboring the BRAF V600E Mutation |
| Q41875891 | Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal Adenocarcinoma |
| Q36567499 | Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon |
| Q35175269 | Clonality and evolutionary history of rhabdomyosarcoma |
| Q34997425 | Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency |
| Q34359322 | Comprehensive mutation analysis in colorectal flat adenomas |
| Q40305624 | Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling |
| Q33904170 | DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability |
| Q61865606 | DNA methylation changes in ex-adenoma carcinoma of the large intestine |
| Q33754380 | DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset |
| Q37164481 | Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas |
| Q53141713 | Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics. |
| Q37129749 | Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1. |
| Q33541307 | Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study |
| Q41553206 | Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation. |
| Q42755415 | Distinctive crypt shape in a sessile serrated adenoma/polyp: Distribution of Ki67-, p16INK4a-, WNT5A-positive cells and intraepithelial lymphocytes |
| Q39704117 | Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer |
| Q54577179 | EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients. |
| Q27021798 | Endoscopic and histologic characteristics of serrated lesions |
| Q33855895 | Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia |
| Q36529734 | Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma |
| Q81142727 | Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases |
| Q51134123 | Extent of field change in colorectal cancers with BRAF mutation. |
| Q64905926 | Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients. |
| Q92840751 | Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma of the colorectum |
| Q35024163 | Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. |
| Q37040359 | Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context. |
| Q46729226 | Gene profiling of colonic serrated adenomas by using oligonucleotide microarray |
| Q52670882 | Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study. |
| Q37122495 | Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer |
| Q38191462 | Genetic unraveling of colorectal cancer |
| Q92716660 | Genomics and metagenomics of colorectal cancer |
| Q36563097 | HLA Class I Expressions on Peripheral Blood Mononuclear Cells in Colorectal Cancer Patients |
| Q35875965 | HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences |
| Q36717750 | Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing |
| Q48657546 | Histopathological diagnosis and differential diagnosis of colorectal serrated polys: findings of a consensus conference of the working group "gastroenterological pathology of the German Society of Pathology" |
| Q42145847 | Hyperplastic Polyposis Syndrome Identified with a BRAF Mutation |
| Q36401708 | Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial |
| Q34867868 | Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin |
| Q36850060 | Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells. |
| Q39514200 | Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation. |
| Q28083455 | Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis |
| Q33828527 | Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome |
| Q34224853 | Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma |
| Q34720314 | Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation. |
| Q34614910 | Management of serrated adenomas and hyperplastic polyps |
| Q58724203 | Merkel cell polyomavirus and Langerhans cell neoplasm |
| Q35596441 | Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer |
| Q30811836 | Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes |
| Q37606161 | Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article |
| Q37139174 | Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention |
| Q61958838 | Molecular patterns in the evolution of serrated lesion of the colorectum |
| Q35819037 | My approach to serrated polyps of the colorectum |
| Q37267219 | Nomenclature, molecular genetics and clinical significance of the precursor lesions in the serrated polyp pathway of colorectal carcinoma. |
| Q54497124 | Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. |
| Q35965705 | Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics |
| Q39453559 | Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment |
| Q35095334 | RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers |
| Q36002845 | Raf kinases: function, regulation and role in human cancer |
| Q51975603 | Relationship of BRAF mutation, morphology, and apoptosis in early colorectal cancer. |
| Q36800212 | Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer. |
| Q26827208 | Serrated lesions of the colorectum: review and recommendations from an expert panel |
| Q34005349 | Serrated neoplasia of the colorectum |
| Q38473801 | Serrated neoplasia-role in colorectal carcinogenesis and clinical implications |
| Q38015332 | Serrated polyposis syndrome: molecular, pathological and clinical aspects |
| Q24623224 | Serrated polyposis: an enigmatic model of colorectal cancer predisposition |
| Q33628909 | Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)-proposal for diagnostic criteria |
| Q80196417 | Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? |
| Q36230771 | Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner |
| Q36693976 | Sessile serrated adenomas: high-risk lesions? |
| Q36221351 | Significance of serrated polyps of the colon |
| Q26795609 | Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance |
| Q38239612 | Targeting BRAF mutant metastatic colorectal cancer: clinical implications and emerging therapeutic strategies |
| Q40154931 | Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance. |
| Q37172151 | The genomics of colorectal cancer: state of the art. |
| Q26738611 | The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysis |
| Q53619358 | Tracing origin of serrated adenomas with BRAF and KRAS mutations. |
| Q33722761 | Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis |
| Q42059658 | V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a |
Search more.